William Baker
Internal Medicine · Abingdon, VANPI 1124196787
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $961 and has fallen 59.5% since, to $389 in 2021.
Across 137 payments — averaging $15.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$482
- Lilly USA, LLC$309
- Johnson & Johnson$248
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$147
- GSK$104
- Amarin Pharma, Inc.$92
- plus $749 from 18 others
What the payments were for
- Food & beverage$2,130100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $482 |
| Lilly USA, LLC | 14 | $309 |
| Johnson & Johnson | 18 | $248 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $147 |
| GSK | 8 | $104 |
| Amarin Pharma, Inc. | 6 | $92 |
| Pfizer | 7 | $87 |
| Arbor Pharmaceuticals, Inc. | 6 | $87 |
| Esperion Therapeutics, Inc. | 4 | $79 |
| Merck | 6 | $75 |
| AbbVie(2 entities) | 4 | $55 |
| Daiichi Sankyo Inc. | 3 | $48 |
| Boehringer Ingelheim | 3 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $36 |
| Sunovion Pharmaceuticals Inc. | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Novartis | 2 | $29 |
| Amgen | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$115
How this compares
$2,130 in reported general payments places this provider in the 85th percentile of 2,724 internal medicine providers in Virginia.
Other internal medicine in Abingdon
- Clinton SutherlandAbingdon$24K
- Kumar AbhishekMechanicsville$1M
- Amit MahajanFalls Church$1M
- Kevin DonohueFalls Church$655K
- Denise BrunerArlington$227K
- Anjali KaloreMidlothian$215K
- Scott GerrishVienna$207K
- Lawrence SchwartzRichmond$205K
- Wally SmithRichmond$177K
- Gautam GulatiMc Lean$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.